BMS-986504
CA240-0005
Phase 2 small_molecule active
Quick answer
BMS-986504 for Solid Tumors is a Phase 2 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active